TY - JOUR
T1 - Clinical experience of 13 cases with severe pulmonary hemorrhage in systemic lupus erythematosus with active nephritis
AU - Liu, Ming-Fei
AU - Lee, Jiann Hsiung
AU - Weng, Tien Hsinng
AU - Lee, Yu-Yun
PY - 1998/9/19
Y1 - 1998/9/19
N2 - Pulmonary hemorrhage is a rare, but serious manifestation of systemic lupus eythematosus (SLE). Herein, we report 13 cases of severe pulmonary hemorrhage in SLE. Hemoptysis was present in 11 patients. All thirteen patients had active nephritis and were in the stage of nephrotic syndrome. A majority of the patients had neuropsychiatric manifestations and coagulopathy including thrombocytopenia or lupus anticoagulant. All episodes of pulmonary hemorrhage occurred after large dose of corticosteroid had been administered in treating nephritis. Recurrent pulmonary hemorrhage was noted in four patients. Ten (77%) of the 13 patients finally died. Respiratory failure was the main cause of death. Our observation suggests that active nephritis with hypoalbuminemia is a major risk factor for severe pulmonary hemorrhage in SLE patients and that high dose corticosteroid use can not prevent the occurrence of severe pulmonary hemorrhage in SLE.
AB - Pulmonary hemorrhage is a rare, but serious manifestation of systemic lupus eythematosus (SLE). Herein, we report 13 cases of severe pulmonary hemorrhage in SLE. Hemoptysis was present in 11 patients. All thirteen patients had active nephritis and were in the stage of nephrotic syndrome. A majority of the patients had neuropsychiatric manifestations and coagulopathy including thrombocytopenia or lupus anticoagulant. All episodes of pulmonary hemorrhage occurred after large dose of corticosteroid had been administered in treating nephritis. Recurrent pulmonary hemorrhage was noted in four patients. Ten (77%) of the 13 patients finally died. Respiratory failure was the main cause of death. Our observation suggests that active nephritis with hypoalbuminemia is a major risk factor for severe pulmonary hemorrhage in SLE patients and that high dose corticosteroid use can not prevent the occurrence of severe pulmonary hemorrhage in SLE.
UR - http://www.scopus.com/inward/record.url?scp=0031670595&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031670595&partnerID=8YFLogxK
U2 - 10.1080/030097498442406
DO - 10.1080/030097498442406
M3 - Article
C2 - 9751470
AN - SCOPUS:0031670595
SN - 0300-9742
VL - 27
SP - 291
EP - 295
JO - Scandinavian Journal of Rheumatology
JF - Scandinavian Journal of Rheumatology
IS - 4
ER -